- Home
- QH vs GCTK Comparison
QH vs GCTK Comparison
Compare QH & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QH | GCTK |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 1.3M |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | QH | GCTK |
|---|---|---|
| Price | $0.10 | $0.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 2.4M |
| Earning Date | 04-02-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 31.22 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.86 | ★ $0.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.06 | $0.09 |
| 52 Week High | $10.85 | $15.90 |
Technical Indicators
Market Signals| Indicator | QH | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 30.16 | 39.14 |
| Support Level | $0.09 | $0.62 |
| Resistance Level | $0.11 | $1.00 |
| Average True Range (ATR) | 0.02 | 0.11 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 60.67 | 40.37 |
Price Performance
Historical ComparisonAbout QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.